Avalo Therapeutics Inc (AVTX) Directors and Executive Officers

Officers & Directors

Christopher Sullivan
Chief Financial Officer

Mitchell Chan
Director

Samantha Truex
Director

Jonathan Goldman, M.D.
Director

Gilla Kaplan, Ph.D.
Director

Aaron Kantoff
Director

Garry Neil, M.D.
President and Chief Executive Officer, Chairman of the Board of Directors and Director

Almenoff, M.D., Ph.D.
Director

Magnus Persson, M.D., Ph.D.
Director ,

Avalo Therapeutics Inc currently has 33 employees.

News about Avalo Therapeutics Inc Key Personnel

Unlocking Potential: Avalo Therapeutics Urges Stockholders to Vote in Favor of Reverse Stock Split for Future Prosperity

Introduction
Avalo Therapeutics, Inc. (Nasdaq: AVTX) has recently called on its stockholders to actively participate in the adjourned annual meeting of stockholders. The meeting, initially held on December 5, 2023, lacked the required quorum to approve the crucial reverse stock split proposal. Avalo Therapeutics is strongly encouraging its stockholders to vote in favor of the proposal, emphasizing the potential benefits it holds for the company s future growth and development.
The Importance of the Reverse Stock Split
A reverse stock split involves the consolidation of a company s shares, reducing the number of outstanding shares while increasing their individual value. Avalo Therapeutics be...